Correlation Between Merus BV and Stoke Therapeutics
Can any of the company-specific risk be diversified away by investing in both Merus BV and Stoke Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Merus BV and Stoke Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Merus BV and Stoke Therapeutics, you can compare the effects of market volatilities on Merus BV and Stoke Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Merus BV with a short position of Stoke Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Merus BV and Stoke Therapeutics.
Diversification Opportunities for Merus BV and Stoke Therapeutics
0.26 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Merus and Stoke is 0.26. Overlapping area represents the amount of risk that can be diversified away by holding Merus BV and Stoke Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Stoke Therapeutics and Merus BV is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Merus BV are associated (or correlated) with Stoke Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Stoke Therapeutics has no effect on the direction of Merus BV i.e., Merus BV and Stoke Therapeutics go up and down completely randomly.
Pair Corralation between Merus BV and Stoke Therapeutics
Given the investment horizon of 90 days Merus BV is expected to under-perform the Stoke Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Merus BV is 1.41 times less risky than Stoke Therapeutics. The stock trades about -0.24 of its potential returns per unit of risk. The Stoke Therapeutics is currently generating about -0.03 of returns per unit of risk over similar time horizon. If you would invest 1,240 in Stoke Therapeutics on August 30, 2024 and sell it today you would lose (49.00) from holding Stoke Therapeutics or give up 3.95% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Merus BV vs. Stoke Therapeutics
Performance |
| Timeline |
| Merus BV |
| Stoke Therapeutics |
Merus BV and Stoke Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Merus BV and Stoke Therapeutics
The main advantage of trading using opposite Merus BV and Stoke Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Merus BV position performs unexpectedly, Stoke Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Stoke Therapeutics will offset losses from the drop in Stoke Therapeutics' long position.| Merus BV vs. Anebulo Pharmaceuticals | Merus BV vs. Adagene | Merus BV vs. Acrivon Therapeutics, Common | Merus BV vs. AnaptysBio |
| Stoke Therapeutics vs. Ikena Oncology | Stoke Therapeutics vs. Eliem Therapeutics | Stoke Therapeutics vs. HCW Biologics | Stoke Therapeutics vs. RenovoRx |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the CEOs Directory module to screen CEOs from public companies around the world.
Other Complementary Tools
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing |